Contract Research Outsourcing - Global Strategic Business Report - Product Image

Contract Research Outsourcing - Global Strategic Business Report

  • ID: 347964
  • Report
  • Region: Global
  • 282 Pages
  • Global Industry Analysts, Inc
1 of 4

FEATURED COMPANIES

  • ICON plc (Ireland)
  • INC Research, LLC (USA)
  • Pharmaron (China)
  • SynteractHCR (USA)
  • WuXi AppTec (China)
  • MORE
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Contract Research Outsourcing in US$ Million by the following Service Segments: Drug Discovery, Preclinical Research, and Clinical Research.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 115 companies including many key and niche players such as:
  • Albany Molecular Research, Inc.
  • Charles River Laboratories International, Inc.
  • Chiltern International Ltd.
  • ICON plc
  • INC Research, LLC
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ICON plc (Ireland)
  • INC Research, LLC (USA)
  • Pharmaron (China)
  • SynteractHCR (USA)
  • WuXi AppTec (China)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Outsourcing of R&D Projects to Propel CROs Services Market
Growth Drivers in a Nutshell
Evolving Macro Trends Driving CRO Demand
CROs to Significantly Drive Outsourcing Penetration
Focus on Efficient, Quality Services to Drive Specialty CROs Market
Rise in Investments to Boost Growth
Key Therapeutic Areas of Clinical Trial Research
Table 1: Global Clinical Trial Services Market by Therapeutic Area: 2016 (includes corresponding Graph/Chart)
Primary Factors Influencing CRO Market
Pharma and Biotech Companies to Increase Dependence on CROs
Outlook
Notable Regional Developments
Future Model of CRO

2. COMPETITIVE SCENARIO
CRO
A Highly Fragmented Market
Table 2: Leading Players in the Global Contract Research Outsourcing Market (2016E): Percentage Breakdown of Revenues by Player (includes corresponding Graph/Chart)
Table 3: Percentage Breakup of Life Sciences Revenues (2016) of Major Players by Service Type- Preclinical, Phase I, Phase IIA, Phase IIB, Phase III, Phase IV/ Post-Approval, Central Lab and Others
Large CROs Seek the Inorganic Growth Route
Global CRO Marketspace
A Review of the M&A Activity in the Recent Years
Select M&A Activity in the Global CRO Market
Noteworthy Contracts of Major CROs
CROs Adept with New Technologies to See More Business in Future
Streamlining Development of Novel Trial Designs
CROs with End-to End Capabilities in Demand
Key Opportunities for CROs
Technological Superiority
A Definite Advantage
Strategies and Tactical Programs for CROs
Survival Strategies in Mature CRO Markets
Strategies to Tap Opportunities in Growing Markets

3. GROWTH DRIVERS, MARKET TRENDS & ISSUES
Increased Spend on R&D Outsourcing
Table 4: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
Table 5: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2016E (includes corresponding Graph/Chart)
Enhancing Site Selection and Patient Enrollment
CROs Enter into Alliances to Improve Efficiencies
Adoption of Digital Technologies Gains Pace
Rising Late-Stage Services Demand and Budget Restraints Drive Market Growth
Toxicology Services Gain Notable Attention
Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
A Mutually Beneficial Strategy
Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
Table 6: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart)
Table 7: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals (includes corresponding Graph/Chart)
Focus on Regulatory Oversight and Enhanced Transparency Bodes Well for CROs
eClinical Solutions Gain Traction
Other Noteworthy Market Trends
CROs Monetize Data
Service Differentiation
A Sustaining Strategy
CROs Tie Up with Diagnostic Companies for Patients
Research Networks Move to Cloud
Application of Mobile Devices to Collect Real Time Data Gains Ground
CROs Provide Exclusive Offers to Lure Big Pharma
Challenges Faced by Contract Research Organizations
On-shore versus Offshore CRO Business
Cutthroat Competition among CROs
Management of Clinical Investigation
Cost Containment
Safety Concerns on Clinical Trials
Pipeline Blocks
Surging Global Population Offers Increased Growth Opportunities
Table 8: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart)
Aging Population Boosts Opportunities for CRO
Table 9: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)
Table 10: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart)
Increasing Healthcare Expenditure to Spur Demand for Generics
Table 11: Healthcare Spending as a Percentage of GDP by Region (2016E) (includes corresponding Graph/Chart)

4. CONTRACT RESEARCH OUTSOURCING AN INSIGHT

5. RECENT INDUSTRY ACTIVITY
WuXi AppTec Takes Over HD Biosciences
Laboratory Corporation of America Holdings to Acquire Pharmaceutical Product Development
PRA Health Sciences and Takeda Pharmaceutical Inks New Partnership
AMRI Enters into Alliance with Bruker Daltonics and HighRes Biosolutions
Pharmaceutical Product Development Establishes Rare Disease and Pediatric Center of Excellence
Pharmaceutical Product Development to Start Clinical Research Unit in Las Vegas
Bracket Acquires CLINapps
PAREXEL International to Acquire ExecuPharm
Cinven to Takeover BioClinica
ICON to Takeover Clinical Research Management
Pharmaceutical Product Development Acquires Evidera
Velocity Fund Partners Acquires Indipharm
Bioclinica Snaps Up Compass Research
Charles River Laboratories International Takes Over Agilux Laboratories
Charles River Laboratories International Snaps Up Blue Stream Laboratories
Charles River Laboratories International Acquires WIL Research
Pharmaron Announces the Acquisition of Quotient Bioresearch
Amulet Capital Partners Acquires SynteractHCR Holdings
IMS Health Merges with Quintiles
Almac Clinical Technologies Enters into Partnership with inVentiv Health
CSSi LifeSciences Unveils Fully Integrated Medical Device CRO
Lovelace Biomedical Commences Operations as Preclinical CRO
PAREXEL International Inks Services Agreement with Pfizer
BioDuro Commences Operations as a Contract Research and Manufacturing Firm
Charles River Laboratories International Forms Partnership with BioMotiv
Laboratory Corporation of America Acquires Covance
Charles River Laboratories International Snaps Up Oncotest
Chiltern Acquires Theorem Clinical Research
Charles River Laboratories International Takes Over Celsis International
Albany Molecular Research Unveils Integrated Drug Discovery Center

6. FOCUS ON SELECT GLOBAL PLAYERS
Albany Molecular Research, Inc. (USA)
Charles River Laboratories International, Inc. (USA)
Chiltern International Ltd. (UK)
ICON plc (Ireland)
INC Research, LLC (USA)
InVentiv Health, Inc. (USA)
Jubilant Biosys Ltd. (India)
Laboratory Corporation of America® Holdings (USA)
PAREXEL International Corp. (USA)
Pharmaceutical Product Development, LLC. (USA)
Pharmaron (China)
PRA Health Sciences, Inc. (USA)
Quintiles IMS Holdings, Inc. (USA)
Ricerca Biosciences LLC (USA)
Sygnature Discovery Limited (UK)
SynteractHCR (USA)
WuXi AppTec (China)

7. GLOBAL MARKET PERSPECTIVE
Table 12: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Contract Research Outsourcing by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 14: World 14-Year Perspective for Contract Research Outsourcing by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Table 15: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Drug Discovery by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 16: World Historic Review for Contract Research Outsourcing for Drug Discovery by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 17: World 14-Year Perspective for Contract Research Outsourcing for Drug Discovery by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Preclinical Research by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Contract Research Outsourcing for Preclinical Research by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 20: World 14-Year Perspective for Contract Research Outsourcing for Preclinical Research by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Clinical Research by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Contract Research Outsourcing for Clinical Research by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Contract Research Outsourcing for Clinical Research by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Outlook
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
Trial Services Witness Higher Demand
Strong Demand for Data Management Services
Focus on Innovation and Productivity
CROs Focus on Adaptive Clinical Trials
Risk-based Monitoring Catches Pace
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 24: US Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 25: US Historic Review for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 26: US 14-Year Perspective for Contract Research Outsourcing by Service Type
Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

2. CANADA
Market Analysis
Table 27: Canadian Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28: Canadian Historic Review for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 29: Canadian 14-Year Perspective for Contract Research Outsourcing by Service Type
Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Strategic Corporate Development
B.Market Analytics
Table 30: Japanese Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31: Japanese Historic Review for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 32: Japanese 14-Year Perspective for Contract Research Outsourcing by Service Type
Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Outlook
Providers Expand Services in Downstream Drug Development
Strategic corporate developments
Key Players
B.Market Analytics
Table 33: European Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 34: European Historic Review for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 35: European 14-Year Perspective for Contract Research Outsourcing by Service Type
Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Outlook
Asia-Pacific to Push up Volume Share in CRO Market
R&D Outsourcing in Life Sciences on Rise
Focus on Select Regional Markets
China
India
Australia
Superior Clinical Trial Quality
Strategic Corporate Development
Key Players
B.Market Analytics
Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37: Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 38: Asia-Pacific 14-Year Perspective for Contract Research Outsourcing by Geographic Region
Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Table 39: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 40: Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 41: Asia-Pacific 14-Year Perspective for Contract Research Outsourcing by Service Type
Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Outlook
Providers with Specialized Research Techniques to Boost Latin American CRO Market
B.Market Analytics
Table 42: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 43: Rest of World Historic Review for Contract Research Outsourcing by Service Type
Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 44: Rest of World 14-Year Perspective for Contract Research Outsourcing by Service Type
Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 115 (including Divisions/Subsidiaries 120)

  • The United States (47)
  • Canada (5)
  • Japan (1)
  • Europe (27)
    • France (2)
    • Germany (6)
    • The United Kingdom (3)
    • Spain (1)
    • Rest of Europe (15)
  • Asia-Pacific (Excluding Japan) (35)
  • Latin America (4)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Albany Molecular Research, Inc. (USA)
  • Charles River Laboratories International, Inc. (USA)
  • Chiltern International Ltd. (UK)
  • ICON plc (Ireland)
  • INC Research, LLC (USA)
  • InVentiv Health, Inc. (USA)
  • Jubilant Biosys Ltd. (India)
  • Laboratory Corporation of America® Holdings (USA)
  • PAREXEL International Corp. (USA)
  • Pharmaceutical Product Development, LLC. (USA)
  • Pharmaron (China)
  • PRA Health Sciences, Inc. (USA)
  • Quintiles IMS Holdings, Inc. (USA)
  • Ricerca Biosciences LLC (USA)
  • Sygnature Discovery Limited (UK)
  • SynteractHCR (USA)
  • WuXi AppTec (China)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll